Release Date: November 07, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you review the size of the lending book and provide an update on the status with your large borrower? A: We have approximately $31 million as a net balance related to the loan box specialty lending segment as of September 30, which is a decline of over $3 million from the previous balance. We are cautiously looking at new loans and plan to invest judiciously in low-risk, accretive loans. Our largest borrower's loans are in non-approval status, and we are working to increase collections through legal methods. There have been no changes to our credit loss reserve this quarter.
Q: Is there anything structurally affecting the industrial assets business, or was it just smaller activities with larger ones pushed to Q4? A: Our pipeline remains strong, and our win rate is fine. Larger transactions were delayed, possibly due to macroeconomic factors, but they are expected to roll into Q4 and Q1. We anticipate having significant quarters ahead despite the recent slow quarter.
Q: Are you planning to shift focus from lending to M&A, given recent industry consolidation? A: Yes, we are considering M&A opportunities as the industry consolidates. We have built up enough cash and credit to pursue acquisitions and aim to be a leader in this consolidation. We are not hoarding cash but are ready to make strategic acquisitions.
Q: What are your goals for potential acquisitions in terms of geography and sector presence? A: We are looking at expanding geographically, particularly outside North America, and enhancing our sector presence. We aim to acquire entities that can significantly contribute to growth, focusing on areas where we can achieve dominance similar to our BioPharma lab sector.
Q: Was having a large concentration with one lender a mistake, and have changes been made to address this risk? A: In retrospect, having too much concentration with one client was a mistake. We have learned from this and plan to lend more judiciously, ensuring a broad client base to avoid dependency on any single entity.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.